RxDoctor Payments DataLook up a doctor →

David Bray, MD

Dermatology · Alexandria, VANPI 1740266386

Payments from drug & device makers

$799,129in general payments, 2019–2025

Across 941 payments — averaging $849.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$345K
  • Eli Lilly$115K
  • Novartis$90K
  • Astrazeneca UK Limited$61K
  • Arcutis Biotherapeutics, Inc.$56K
  • Galderma Laboratories, L.p.$30K
  • plus $102K from 44 others
$10,921in research payments, 2019–2025

Across 13 payments — averaging $840.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$9K
  • Sanofi US Services Inc.$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$799,129 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia

Medicare billing

Part B allowed, 2024
$469,906
Medicare patients
1,230
Services billed
6,194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →